share_log

Invivyd | 4: Statement of changes in beneficial ownership of securities-10% Owner Adimab, LLC

SEC ·  Jan 22 13:00
Summary by Futu AI
Adimab, LLC completed a sale of 5,000,000 shares of Invivyd, Inc. (IVVD) common stock on January 19, 2024. The shares were sold at a price of $3.95 per share, resulting in a total transaction value of $19,750,000. Following the transaction, Adimab, LLC's direct holdings in Invivyd amount to 21,687,906 shares. The sale was conducted in the open market.
Adimab, LLC completed a sale of 5,000,000 shares of Invivyd, Inc. (IVVD) common stock on January 19, 2024. The shares were sold at a price of $3.95 per share, resulting in a total transaction value of $19,750,000. Following the transaction, Adimab, LLC's direct holdings in Invivyd amount to 21,687,906 shares. The sale was conducted in the open market.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated